Rothschild Investment LLC Maxcyte, Inc. Transaction History
Rothschild Investment LLC
- $1.49 Trillion
- Q1 2025
A detailed history of Rothschild Investment LLC transactions in Maxcyte, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 360 shares of MXCT stock, worth $939. This represents 0.0% of its overall portfolio holdings.
Number of Shares
360
Previous 60
500.0%
Holding current value
$939
Previous $250,000
293.2%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding MXCT
# of Institutions
123Shares Held
69.7MCall Options Held
8.7KPut Options Held
6K-
Cadian Capital Management, LP New York, NY9.34MShares$24.4 Million2.26% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$21.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.43MShares$14.2 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$13.2 Million18.06% of portfolio
-
Morgan Stanley New York, NY4.41MShares$11.5 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $265M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...